GGrantIndex
Sort

64,565 grants matching “drug discovery”

Leadership, Planning and Evaluation

$725,691
Raphael E. Pollock · Ohio State University · P30 · FY2025 · CA

Allosteric regulation of lysine degradation as a novel pathophysiological mechanism in glutaric aciduria type 1

$725,640
Sander Michel Houten · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · HD

Allosteric regulation of lysine degradation as a novel pathophysiological mechanism in glutaric aciduria type 1

$725,595
Sander Michel Houten · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HD

Tissue ProcessingSequencing Core

$725,535
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Mechanisms of Resilience to Alzheimer's Disease Neuropathology

$725,531
Giulio Taglialatela · University Of Texas Med Br Galveston · R56 · FY2017 · AG

Epstein-Barr Virus LMP-1 Mediated Oncogenicity

$725,501
Elliott D Kieff · Brigham And Women'S Hospital · R01 · FY2009 · CA

Targeting Mechanistic Subtypes of Neoplastic Disease

$725,453
Michael A White · Ut Southwestern Medical Center · R35 · FY2015 · CA

PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications

$725,450
Daniel R Deaver · Paasp Us, Llc · R44 · FY2021 · DA

Collaboration on preclinical autism cellular assays, biosignatures, and network analyses (Copacabana)

$725,383
Eugene Wei-Ming Yeo · University Of California, San Diego · U19 · FY2017 · MH

Primity Cloud: High-Performance Cytometry Analysis Engine

$725,372
Peter Krutzik · Primity, Inc. · R44 · FY2017 · AI

Role of a psychiatric disease risk factor in synaptic function and gene transcription regulation

$725,330
Hongjun Song · Johns Hopkins University · U19 · FY2016 · MH

(-)-Phenserine inhibition of neuronal death in Alzheimer’s disease and developing brain-labeled plasma exosomes assays as biomarkers for a phenserine phase 1b ascending dose trial

$725,263
Lon S Schneider · University Of Southern California · R01 · FY2019 · AG

Artificial Antibody Mimetics

$725,229
Syntrix Biosystems, Inc. · R44 · FY2005 · CA

In silico safety pharmacology

$725,146
Colleen E Clancy · University Of California At Davis · R01 · FY2021 · HL

Integrated Platform for the Discovery of Antibacterial

$725,136
Suzanne L. Walker · Harvard Medical School · U19 · FY2014 · AI

Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease

$725,129
Rima F Kaddurah-Daouk · Duke University · R01 · FY2023 · AG

Molecular Targets for Drug Discovery in IPF

$725,051
Peter B Bitterman · University Of Minnesota · R01 · FY2006 · HL

MRI: Acquisition of a Massive Database to Accelerate Data Science Discovery

$725,016
Christopher M Danforth · University Of Vermont & State Agricultural College · · FY2021 · MPS

GOALI: Advancing a Mechanism-Driven Predictive Model for the Catalyst-controlled Asymmetric Rh(I)-Catalyzed Pauson-Khand Reaction

$725,000
Kay M Brummond · University Of Pittsburgh · · FY2025 · MPS

CWRU OBRIEN RENAL RESEARCH CENTER

$725,000
Case Western Reserve University · P50 · FY2002 · DK

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGENS

$724,983
Timothy A Springer · Immune Disease Institute, Inc. · R37 · FY2008 · CA

JAK1/2 as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target

$724,958
David C Fajgenbaum · University Of Pennsylvania · R01 · FY2025 · HL

Chemical biology of Peptide Regulation of Opioid Receptor Function

$724,924
Carrie Haskell-Luevano · University Of Minnesota · R01 · FY2020 · DA

Rechargeable Anti-thrombogenic Films for Blood Contacting Applications

$724,920
Elliot Chaikof · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL

Longitudinal Discovery of Brain Developmental Trajectories

$724,916
Michael Peter Milham · Nathan S. Kline Institute For Psych Res · U01 · FY2015 · MH